Skip to main content Accessibility help
  • Print publication year: 2012
  • Online publication date: October 2012

Chapter 21 - Genetics and common human obesity


The initial search for attention-deficit hyperactivity disorder (ADHD) genes was hypothesis driven and focused on genes involved in neurotransmission, based on evidence from effective pharmacotherapeutic agents, animal model, and neuroimaging studies. Candidate genes, linkage, and genome-wide analyses studies (GWAS) have identified several gene variants involved in neurotransmission which confer a modest risk for ADHD. It is also possible that few common variants conferring risk for ADHD exist in the European population and that very large samples will be necessary to identify them. Structural variant studies are indicating that ADHD genetic risk is likely to be transmitted largely by rare variants that collectively disrupt a sizable constellation of genes, presumably with related functions. This is supported by animal genetic models which also implicate numerous genes involved in complex interactions between neural pathways. Epigenetic factors, environmental factors, and gene regulatory elements most likely also play a role in ADHD genetics.


1. Flegal KM, et al. JAMA 2010;303:235–241.
2. Hodge AM, et al. Int J Obes Relat Metab Disord 1994;18:419–428.
3. Price RA, et al. Am J Phys Anthropol 1993;92:473–479.
4. Sugarman JR, et al. Am J Clin Nutr 1990;52:960–966.
5. Bleich S, et al. Annu Rev Public Health 2008;29:273–295.
6. Kumanyika SK. Annu Rev Public Health 2008;29:297–302.
7. Silventoinen K, et al. Int J Obes Relat Metab Disord 2004;28:710–718.
8. Maes HH, et al. Behav Genet 1997;27:325–351.
9. Malis C, et al. Obes Res 2005;13:2139–2145.
10. Stunkard AJ, et al. JAMA 1986;256:51–54.
11. Bouchard C, et al. J Nutr 1997;127:S943–S947.
12. Lu Qi YAC. Nutrition Reviews 2008;66:684–694.
13. Farooqi S, et al. Endocr Rev 2006;27:710–718.
14. Rankinen T, et al. Obesity 2006;14:529–644.
15. Bodmer W, et al. Nat Genet 2008;40:695–701.
16. Iyengar SK, et al. Methods Mol Biol 2007;376:71–84.
17. Cooper GM, et al. Nat Genet 2007;39:S22–S29.
18. Wong KK, et al. Am J Hum Genet 2007;80:91–104.
19. Cook Jr EH, et al. Nature 2008;455:919–923.
20. Estivill X, et al. PLoS Genetics 2007;3:e190.
21. Wang K, et al. Diabetes 2010;59(10):2690–2694.
22. Sha BY, et al. J Hum Genet 2009;54:199–202.
23. Bochukova EG, et al. Nature 2010;463:666–670.
24. Walters RG, et al. Nature 2010;463:671–675.
25. Glessner JT, et al. Am J Hum Genet 2010;87:661–666.
26. Jarick I, et al. Human Molecular Genetics 2011;20:840–852.
27. Saunders CL, et al. Obesity (Silver Spring) 2007;15:2263–2275.
28. Sham PC, et al. Am J Human Genetics 2000;66:1616–1630.
29. Risch N, et al. Science 1996;273:1516–1517.
30. International HapMap Consortium. Nature 2007;449:851–861.
31. The Wellcome Trust Case Control Consortium. Nature 2007;447:661–678.
32. Loos RJ, et al. Nat Genet 2008;40:768–775.
33. Lindgren CM, et al. PLoS Genet 2009;5:e1000508.
34. Scherag A, et al. PLoS Genet 2010;6:e1000916.
35. Thorleifsson G, et al. Nat Genet 2009;41:18–24.
36. Willer CJ, et al. Nat Genet 2009;41:25–34.
37. Heard-Costa NL, et al. PLoS Genet 2009;5:e1000539.
38. Heid IM, et al. Nat Genet 2010;42:949–960.
39. Speliotes EK, et al. Nat Genet 2010;42:937–948.
40. Gudbjartsson DF, et al. Nat Genet 2008;40:609–615.
41. Lettre G, et al. Nat Genet 2008;40:584–591.
42. Weedon MN, et al. Nat Genet 2008;40:575–583.
43. Visscher PM. Nat Genet 2008;40:489–490.
44. Fisher RA. Transactions of the Royal Society of Edinburg 1918;52:399–433.
45. Feinberg AP, et al. Nature 2007;447:433–440.
46. Reik W, et al. Nat Rev Genet 2001;2:21–32.
47. Wilkinson LS, et al. Nat Rev Neurosci 2007;8:832–843.
48. Wood AJ, et al. PLoS Genet 2006;2:e147.
49. Vrana PB, et al. Nat Genet 1998;20:362–365.
50. Nezer C, et al. Nat Genet 1999;21:155–156.
51. de Koning DJ, et al. Proc Natl Acad Sci U S A 2000;97:7947–7950.
52. Kong A, et al. Nature 2009;462:868–874.
53. Dong C, et al. Am J Hum Genet 2005;76:427–437.
54. Luedi PP, et al. Genome Res 2005;15:875–884.
55. Bell CG, et al. Nat Rev Genet 2005;6:221–234.
56. Ravelli GP, et al. N Engl J Med 1976;295:349–353.
57. Hales CN, et al. Br Med Bull 2001;60:5–20.
58. Pettitt DJ, et al. N Engl J Med 1983;308:242–245.
59. Tamashiro KL, et al. Diabetes 2009;58:1116–1125.
60. Yazbek SN, et al. Hum Mol Genet 2010;19:4134–4144.
61. Heijmans BT, et al. Proc Natl Acad Sci U S A 2008;105:17046–17049.
62. Pietilainen KH, et al. PLoS Med 2008;5:e51.
63. Chen Y, et al. Nature 2008;452:429–435.
64. Koza RA, et al. PLoS Genet 2006;2:e81.
65. Weinshilboum R. Med Biol 2008;630:220–231.
66. Muller DJ, et al. Pharmacogenomics 2006;7:863–887.
67. Spraggs CF, et al. Pharmacogenet Genomics 2005;15:883–889.
68. Eichler EE, et al. Nat Rev Genet 2010;11:446–450.
69. Thomas A, et al. Annals of Human Genetics 2008;72:279–287.
70. Zhu X, et al. Genetic Epidemiology 2010;34:171–187.